References
- 4. Pegon Ch, Rochette E, Rouel N, et al. Childhood Leukemia Survivors and Metabolic Response to Exercise: A Pilot Controlled Study, J Clin Med. 2020;9(2):562, DOI: 10.3390/jcm902056210.3390/jcm9020562707362232092881
- 5. Derwich K, Zając-Spychała O. Zaburzenia genetyczne w ostrej białaczce limfoblastycznej u dzieci i ich wykorzystanie w praktyce klinicznej. Hematologia. 2012;3(3):221-230.
- 6. Mały E, Przyborska M, Derwich K, et al. Zmiany cytogenetyczne a pozostałe czynniki prognostyczne u dzieci z ostrą białaczką limfoblastyczną - badania jednoośrodkowe. Acta Haematologica Polonica. 2011;42(3): 507-512.
- 7. Bulas M, Pierlejewski F, Młynarski W. Glikokortykosteroidooporność w chorobach limfoproliferacyjnych u dzieci. Przegląd pediatryczny. 2009;39(1):57-61.
- 8. Li R, Donnella H, Knouse P, et al. A randomized nutrition counseling intervention in pediatric leukemia patients receiving steroids results in reduced caloric intake. Pediatr Blood Cancer. 2017;64:374-380. DOI: 10.1002/pbc.2623110.1002/pbc.2623127615542
- 9. Reilly JJ, Brougham M, Montgomery C, et al. Effect of Glucocorticoid Therapy on Energy Intake in Children Treated for Acute Lymphoblastic Leukemia. The Journal of Clinical Endocrinology & Metabolism. 2001;86(8):3742-3745. DOI: 10.1210/jcem.86.8.776410.1210/jcem.86.8.776411502805
- 10. Marchewka Z, Guzy K, Robach-Dolata A, et al. Leki jako czynniki ryzyka rozwoju hiperglikemii oraz mechanizmy ich działania diabetogennego. Farm Pol. 2017;73(2): 105-114.
- 11. Esbenshade AJ, Simmons JH, Koyama T, et al. Body mass index and blood pressure changes over the course of treatment of pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer. 2011;56:372-378. DOI: 10.1002/pbc.2278210.1002/pbc.22782371322520860019
- 12. Kułaga Z, Różdżyńska-Świątkowska A, Grajda A, et al. Siatki centylowe dla oceny wzrastania i stanu odżywienia polskich dzieci i młodzieży od urodzenia do 18 roku życia. Standardy Medyczne. Pediatria. 2015;12:119-135.
- 13. www.cdc.gov/growthcharts, accessed on: 04.07.2020
- 14. Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics 2017;140(3): e20171904. DOI: 10.1542/peds.2017-190410.1542/peds.2017-190428827377
- 15. Pisarczyk-Wiza D, Zozulińska-Ziółkiewicz D. Glikokortykosteroidy a zaburzenia metabolizmu glukozy. Diabetologia Kliniczna. 2015;4(3): 110-116.10.5603/DK.2015.0010
- 16. Banecka B, Lesiuk M, Beń-Skowronek I, et al. Przejściowe zaburzenia gospodarki węglowodanowej w czasie intensywnego leczenia ostrej białaczki limfoblastycznej u dzieci. Endokrynologia Pediatryczna. 2013;3 (44): 47-52.
- 17. Hijiya N, van der Sluis I. Asparaginase-associated toxicity in children with acute lymphoblastic leukemia, Leukemia & Lymphoma. 2016;57(4):748–757. DOI: 10.3109/10428194.2015.110109810.3109/10428194.2015.1101098481984726457414
- 18. Lowas SR, Marks D, Malempati S. Prevalence of transient hyperglycemia during induction chemotherapy for pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer. 2009;52: 814-818. DOI 10.1002/pbc.2198010.1002/pbc.2198019260096
- 19. Aisyi M, Andriastuti M, Kurniati N. The Effect of Combination of Steroid and L-Asparaginase on Hyperglycemia in Children with Acute Lymphoblastic Leukemia (ALL), Asian Pac J Cancer Prev. 2019;1;20(9):2619-2624. DOI: 10.31557/APJCP.2019.20.9.261910.31557/APJCP.2019.20.9.2619697682331554355
- 20. Jansen H, Postma A, Stolk RP, Kamps WA. Acute lymphoblastic leukemia and obesity: increased energy intake or decreased physical activity? Support Care Cancer. 2009;17(1):103-106. DOI: 10.1007/s00520-008-0531-010.1007/s00520-008-0531-018989711
- 21. Van Dongen-Melman JEWM, Hokken-Koelega ACS, Hählen K, et al. Obesity after successful treatment of acute lymphoblastic leukemia in childhood. Pediatric Research 1995;38 (1): 86-90. DOI: 10.1203/00006450-199507000-0001510.1203/00006450-199507000-000157478803
- 22. Iughetti L, Bruzzi P, Predieri B, et al. Obesity in patients with acute lymphoblastic leukemia in childhood. Italian Journal of Pediatrics. 2012;38 (4):2-11.10.1186/1824-7288-38-4329571222284631
- 23. Veringa SJE, van Dulmen - den Broeder E, Gertjan JL Kaspersky GJL, et al. Blood pressure and body composition in long-term survivors of childhood acute lymphoblastic leukemia, Pediatr Blood Cancer 2012;58: 278–282, DOI: 0.1002/pbc.2325110.1002/pbc.2325121793179
- 24. Pegon Ch, Rochette E, Rouel N, et al. Childhood Leukemia Survivors and Metabolic Response to Exercise: A Pilot Controlled Study, J Clin Med. 2020;9(2):562, DOI: 10.3390/jcm902056210.3390/jcm9020562707362232092881
- 25. Alias H, Mohd Nazi NA, Lau Sie Chong D. Participation in Physical Activity and Physical Education in School Among Children With Acute Lymphoblastic Leukemia After Intensive Chemotherapy, Front Pediatr. 2019;7: 73. DOI: 10.3389/fped.2019.0007310.3389/fped.2019.00073643164830937299
- 26. Beaulieu-Gagnon S, Bélanger V, Meloche C. Nutrition education and cooking workshops for families of children with cancer: a feasibility study, BMC Nutr. 2019;19; 5:52. DOI: 10.1186/s40795-019-0319-210.1186/s40795-019-0319-2705088132153965
- 27. Sonabend RY, McKay SV, Oncu MF, et al. Hyperglycemia during induction therapy is associated with increased infectious complications in childhood acute lymphocytic leukemia. Pediatr Blood Cancer. 2008;51: 387-392. DOI 10.1002/pbc.2162410.1002/pbc.2162418523991
- 28. O’Connor D, Bate J, Wade R. Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL 2003, Blood. 2014;124(7):1056–1061. DOI: 10.1182/blood-2014-03-56084710.1182/blood-2014-03-56084724904116
- 29. Weiser MA, Cabanillas ME, Konopleva M i wsp. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen. Cancer. 2004;100 (6):1179-1185. DOI: 10.1002/cncr.20071.10.1002/cncr.2007115022284